Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
LeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc. (LMAT) Stock Ticker

NASDAQ: LMAT · Healthcare · Medical - Instruments & Supplies
$81.52+0.87%
USD · as of 2026-09-28 · market cap $1.9B
Open LMAT in TickrDownload for iPhone

LMAT right now

Options expect by Oct 6±3.3%
Options expect by Oct 29±6.9%
Priced in for Nov 5 earnings±7.6%
IV rank (30-day)7% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full LMAT picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on LMAT
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About LeMaitre Vascular, Inc.

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.

LMAT stock facts

Ticker symbolLMAT
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryMedical - Instruments & Supplies
Market cap$1.9B
CEOGeorge W. LeMaitre
Employees651
HeadquartersBurlington, MA, US
IPO date2006-10-19
Websitewww.lemaitre.com

What you can see for LMAT on Tickr

Live LMAT price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LMAT report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for LeMaitre Vascular, Inc.?

The ticker symbol for LeMaitre Vascular, Inc. is LMAT, listed on the NASDAQ Global Market.

What is LMAT?

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins;…

HomeExploreMarketLists
All pages